E2F1 and neoplasm: Additionally, ATAC‐seq and gene array analyses have further uncovered that CLF amplifies the anti‐tumour capacity of tumour‐specific CD8+ T cells through the upregulation of E2F1‐induced Tcf7 promoter activation.